- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01514331
Ventilatory Parameters and Inflammatory Responses of Neonates Ventilated by Different Modes of Ventilation
Determination of Ventilatory Parameters and Inflammatory Responses of Neonates Who Are Ventilated by Volume Guarantee Combined With Synchronized Intermittent Mandatory Ventilation or Pressure Support Ventilation
Study Overview
Status
Detailed Description
Term or preterm neonates may need mechanical ventilation due to different etiologies. In all patients aim of mechanical ventilation is to promote pulmonary gas exchange, reduce the respiratory work of patient. Ideal mechanical ventilation must minimize pulmonary trauma with low inspiratory pressures that obtains adequate and constant tidal volumes. Ventilation associated pulmonary injury is an important subject that must be considered during mechanical ventilation. Atelectotrauma, volutrauma, barotrauma and biotrauma must be monitored. Volutrauma, barotrauma and oxygen toxicity cause cytokine increase that results in biotrauma. This parenchymal inflammation is a risk factor for chronic lung disease which is an important morbidity of ventilated neonates.
From past to present neonates were ventilated with different ventilation modes including IMV (Intermittent Mandatory Ventilation), SIMV, A/C (Assist Control Ventilation), PSV,HFV (High Frequency Ventilation). Both PSV and SIMV are patient trigger ventilation modes but SIMV is a time cycled and PSV is a flow cycled mode. In recent years hybrid techniques were developed to combine beneficial features of volume and pressure limited ventilation. In commercial ventilation devices these techniques have different names as volume guaranteed pressure limited ventilation (Drager Babylog 8000), pressure regulated volume controlled ventilation (Siemens servo 3000), volume guaranteed pressure support ventilation (VIP Bird Gold).
Since there is not a standard protocol for mechanical ventilation of neonates different countries and even different NICU's use different ventilation protocols.
Literature supports volume targetted ventilation to reduce barotrauma with low maximum inspiratory pressures and to reduce volutrauma with constant tidal volumes. When A/C+VG and SIMV+VG were compared in a crossover trial, more constant tidal volumes were obtained in A/C mode. Inflammatory cytokines have also been measured in different groups of patients with variable ventilatory management techniques. So far there has not been a randomized study published comparing VG+SIMV with VG+PSV in newborns with regards to tidal volume , peak inspiratory pressure variability,or inflammatory cytokines. Therefore in this study the investigators aimed to compare these two ventilation modes with regards to short term outcome.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Ankara
-
Besevler, Ankara, Turkey, 06500
- Gazi University Hospital, Department of Pediatrics, Division of Newborn Medicine
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- neonates with respiratory distress who need mechanical ventilation
- gestational age less than or equal to 37 weeks
- neonates who need mechanical ventilation within first 24 hours
Exclusion Criteria:
- neonates who need mechanical ventilation other than conventional ventilation
Study Plan
How is the study designed?
Design Details
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: PSV+VG
Neonates who require mechanical ventilation and randomised to pressure support + volume guarantee (PSV+VG) mode
|
Neonates who need mechanical ventilation will be ventilated with PSV+VG
Other Names:
|
|
Active Comparator: SIMV+VG
Neonates who require mechanical ventilation and randomised to synchronised intermittant mandatory ventilation + volume guarantee (SIMV+VG) mode
|
Neonates who need mechanical ventilation will be ventilated with SIMV+VG mode
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
IL-1beta levels in tracheal aspirate material
Time Frame: Baseline and 72 hours of mechanical ventilation
|
Tracheal aspirate will be analyzed for the mediator level and change from baseline will be reported
|
Baseline and 72 hours of mechanical ventilation
|
|
IL-6 level in tracheal aspirate
Time Frame: Baseline and 72 hours of mechanical ventilation
|
Tracheal aspirate will be analyzed for IL6 level and the change from baseline will be reported
|
Baseline and 72 hours of mechanical ventilation
|
|
IL-8 in tracheal aspirate material
Time Frame: Baseline and 72 hours of mechanical ventilation
|
Tracheal aspirate will be analyzed for the mediator level and change from baseline will be reported
|
Baseline and 72 hours of mechanical ventilation
|
|
IL-10 level in tracheal aspirate material
Time Frame: Baseline and 72 hours of mechanical ventilation
|
Tracheal aspirate will be analyzed for the mediator level and change from baseline will be reported
|
Baseline and 72 hours of mechanical ventilation
|
|
TNF alfa in tracheal aspirate material
Time Frame: Baseline and 72 hours of mechanical ventilation
|
Tracheal aspirate will be analyzed for the mediator level and change from baseline will be reported
|
Baseline and 72 hours of mechanical ventilation
|
|
tidal volume variability
Time Frame: 72 hours of mechanical ventilation or entire ventilation time if extubated earlier
|
variability in tidal volume measured with babyview program
|
72 hours of mechanical ventilation or entire ventilation time if extubated earlier
|
|
peak inspiratory pressure variability
Time Frame: 72 hours of mechanical ventilation or entire ventilation time if extubated earlier
|
variability in peak inspiratory pressure measured with babyview program
|
72 hours of mechanical ventilation or entire ventilation time if extubated earlier
|
|
respiratory rate variability
Time Frame: 72 hours of mechanical ventilation or entire ventilation time if extubated earlier
|
changes in respiratory rate, tacypnea rate
|
72 hours of mechanical ventilation or entire ventilation time if extubated earlier
|
|
oxygen saturation variability
Time Frame: 72 hours of mechanical ventilation or entire ventilation time if extubated earlier
|
changes in oxygen saturation, desaturation rate, hyperoxy rate
|
72 hours of mechanical ventilation or entire ventilation time if extubated earlier
|
|
lowest carbondioxide level (mmHg)
Time Frame: 72 hours of mechanical ventilation or entire ventilation time if extubated earlier
|
ratio of hypocarbic blood gases and least pCo2 level
|
72 hours of mechanical ventilation or entire ventilation time if extubated earlier
|
|
highest carbondioxide level (mmHg)
Time Frame: 72 hours of mechanical ventilation or entire ventilation time if extubated earlier
|
ratio of hypercarbic blood gases and highest pCo2 level
|
72 hours of mechanical ventilation or entire ventilation time if extubated earlier
|
|
lowest oxygen level (mmHg)
Time Frame: 72 hours of mechanical ventilation or entire ventilation time if extubated earlier
|
ratio of hypoxic blood gases and least pO2 level
|
72 hours of mechanical ventilation or entire ventilation time if extubated earlier
|
|
highest oxygen level (mmHg)
Time Frame: 72 hours of mechanical ventilation or entire ventilation time if extubated earlier
|
ratio of hyperoxic blood gases and highest pO2 level
|
72 hours of mechanical ventilation or entire ventilation time if extubated earlier
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
bronchopulmonary dysplasia
Time Frame: 36 weeks corrected age
|
Oxygen requirement at 36 weeks corrected age
|
36 weeks corrected age
|
|
patent ductus arteriosus
Time Frame: in the first week of post natal life of the patient
|
Presence of hemodynamically significant patent ductus arteriosus in the first 7 days of life
|
in the first week of post natal life of the patient
|
|
necrotizing enterocolitis
Time Frame: 36 weeks corrected age
|
Necrotising entercolitis defined by clinical and radiological findings
|
36 weeks corrected age
|
|
intraventricular hemorrhage
Time Frame: during first week
|
Intraventricular hemorrhage diagnosed by head ultrasound
|
during first week
|
|
pneumothorax
Time Frame: during first 3 days
|
Air leak diagnosed by chest x-ray
|
during first 3 days
|
|
pulmonary interstitial emphysema
Time Frame: during first week
|
Air leak diagnosed by x-ray
|
during first week
|
|
pulmonary hemorrhage
Time Frame: during first week
|
during first week
|
|
|
retinopathy of prematurity
Time Frame: until 36 weeks corrected age
|
Retinal disease diagnosed by indirect opthtalmoscopic exam
|
until 36 weeks corrected age
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Ebru N Ergenekon, MD, Gazi University, Division of newborn Medicine
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 01/2011-68
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Ventilator Induced Lung Injury
-
Ayse UlgeyNot yet recruitingVentilator-induced Lung InjuryTurkey
-
Lungpacer Medical Inc.CompletedVentilator Induced Lung InjuryParaguay
-
Capital Medical UniversityBeijing Tiantan HospitalCompleted
-
Fondazione Policlinico Universitario Agostino Gemelli...Not yet recruitingVentilator-Induced Lung Injury
-
Lingling DingNot yet recruitingElectroacupuncture | Lung Injury, Ventilator Induced
-
University Hospital Bergmannsheil BochumDepartment of Plastic, Reconstructive and Burn Surgery, BG University Hospital... and other collaboratorsNot yet recruitingBurn Injury | Pulmonary Complications | Ventilator-induced Lung Injury (VILI) | Inhalational InjuryGermany
-
Shanghai Zhongshan HospitalUnknownMechanical Ventilation | Transpulmonary Pressure | Ventilator-induced Lung InjuryChina
-
Assistance Publique - Hôpitaux de ParisINSERM UMR-942, Paris, France; M3DISIMNot yet recruitingGeneral Anesthesia | Postoperative Respiratory Complications | Ventilator-Induced Lung InjuriesFrance
-
Peking Union Medical College HospitalShandong Provincial Hospital; Henan Provincial People's Hospital; Chongqing General... and other collaboratorsNot yet recruitingCritical Illness | Respiratory Failure | ARDS (Acute Respiratory Distress Syndrome) | VILI (Ventilator-induced Lung Injury)
-
Kocaeli UniversityCompletedVentilator-Induced Lung Injury | Ventilator Adverse Event | Lung Injury, AcuteTurkey
Clinical Trials on PSV+VG (pressure support ventilation+volume guarantee)
-
Universidade Federal de PernambucoReal Hospital Português de Beneficência em PernambucoCompleted
-
Postgraduate Institute of Medical Education and...CompletedChronic Obstructive Pulmonary Disease | Invasive Mechanical Ventilation | Adaptive Support VentilationIndia
-
Poznan University of Medical SciencesCompletedPremature Birth | Respiratory Failure | Respiratory Distress Syndrome, NewbornPoland
-
ResMedTerminatedChronic Obstructive Pulmonary DiseaseGermany
-
Postgraduate Institute of Medical Education and...CompletedAutomatic Tube Compensation (ATC) for Weaning Patients With Severe Neurotoxic Snake Envenoming (ATC)Mechanical Ventilation | Weaning | Snake BiteIndia
-
South Tees Hospitals NHS Foundation TrustCompletedOxygen Saturation Targetting in Preterm Ventilated InfantsUnited Kingdom
-
Assiut UniversityUnknown
-
Rush University Medical CenterRecruitingSpontaneous Breathing Trial in ICUUnited States
-
Ain Shams UniversityCompletedAcute Hypoxemic Respiratory FailureEgypt
-
University Hospital, CaenCentre d'Investigation Clinique et Technologique 805Unknown